Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-10-01 5:35 pm Sale |
2024-09-27 | 13D | TELA Bio, Inc. TELA |
ORBIMED ADVISORS LLC | 2,124,267 8.600% |
-313,700 (-12.87%) |
Filing History |
| 2024-09-23 6:44 pm Purchase |
2024-09-16 | 13D | Traws Pharma, Inc. TRAW |
ORBIMED ADVISORS LLC | 602,000 19.900% |
602,000 (New Position) |
Filing History |
| 2024-09-23 4:34 pm Purchase |
2024-09-16 | 13D | MBX Biosciences, Inc. Common Stock MBX |
ORBIMED ADVISORS LLC | 3,812,215 12.000% |
3,812,215 (New Position) |
Filing History |
| 2024-09-16 8:29 pm Unchanged |
2024-09-12 | 13D | Terns Pharmaceuticals, Inc. TERN |
ORBIMED ADVISORS LLC | 7,562,971 9.000% |
0 (Unchanged) |
Filing History |
| 2024-09-10 4:12 pm Unchanged |
2024-09-03 | 13D | Xtant Medical Holdings, Inc. XTNT |
ORBIMED ADVISORS LLC | 73,114,592 52.700% |
0 (Unchanged) |
Filing History |
| 2024-08-15 4:47 pm Purchase |
2024-08-13 | 13D | scPharmaceuticals Inc. SCPH |
ORBIMED ADVISORS LLC | 6,059,528 12.100% |
500,000 (+8.99%) |
Filing History |
| 2024-08-15 4:38 pm Sale |
2024-08-13 | 13D | Apollomics, Inc. APLM |
ORBIMED ADVISORS LLC | 500 0.050% |
-85,655 (-99.42%) |
Filing History |
| 2024-08-09 4:09 pm Sale |
2024-07-31 | 13D | Janux Therapeutics, Inc. JANX |
ORBIMED ADVISORS LLC | 1,965,266 3.800% |
-684,198 (-25.82%) |
Filing History |
| 2024-07-18 5:33 pm Sale |
2024-07-16 | 13D | Terns Pharmaceuticals, Inc. TERN |
ORBIMED ADVISORS LLC | 7,562,971 11.700% |
-56,164 (-0.74%) |
Filing History |
| 2024-07-02 4:58 pm Sale |
2024-06-28 | 13D | TELA Bio, Inc. TELA |
ORBIMED ADVISORS LLC | 2,437,967 9.900% |
-428,300 (-14.94%) |
Filing History |
| 2024-06-20 5:15 pm Purchase |
2024-06-17 | 13D | Disc Medicine, Inc. IRON |
ORBIMED ADVISORS LLC | 1,785,571 6.000% |
83,334 (+4.90%) |
Filing History |
| 2024-05-22 7:32 pm Unchanged |
2024-05-20 | 13D | Apollomics, Inc. APLM |
ORBIMED ADVISORS LLC | 86,155 7.900% |
0 (Unchanged) |
Filing History |
| 2024-05-20 4:55 pm Sale |
2024-05-16 | 13D | Enliven Therapeutics, Inc. ELVN |
ORBIMED ADVISORS LLC | 7,918,163 16.800% |
-1,033,300 (-11.54%) |
Filing History |
| 2024-05-08 7:55 pm Unchanged |
2024-05-06 | 13D | Corvus Pharmaceuticals, Inc. CRVS |
ORBIMED ADVISORS LLC | 6,943,654 11.100% |
0 (Unchanged) |
Filing History |
| 2024-04-12 5:35 pm Unchanged |
2024-04-09 | 13D | Passage Bio, Inc. PASG |
ORBIMED ADVISORS LLC | 8,034,000 13.000% |
0 (Unchanged) |
Filing History |
| 2024-04-04 4:39 pm Purchase |
2024-04-02 | 13D | Enliven Therapeutics, Inc. ELVN |
ORBIMED ADVISORS LLC | 8,951,463 19.200% |
2,124 (+0.02%) |
Filing History |
| 2024-03-28 4:28 pm Purchase |
2024-03-26 | 13D | Q32 Bio Inc. QTTB |
ORBIMED ADVISORS LLC | 2,252,987 18.900% |
2,252,987 (New Position) |
Filing History |
| 2024-03-22 4:59 pm Unchanged |
2024-03-21 | 13D | Compass Therapeutics, Inc. CMPX |
ORBIMED ADVISORS LLC | 18,791,422 13.700% |
0 (Unchanged) |
Filing History |
| 2024-03-21 4:31 pm Unchanged |
2024-03-19 | 13D | Adicet Bio, Inc. ACET |
ORBIMED ADVISORS LLC | 9,772,598 11.900% |
0 (Unchanged) |
Filing History |
| 2024-03-08 4:34 pm Sale |
2024-03-06 | 13D | NextCure, Inc. NXTC |
ORBIMED ADVISORS LLC | 1,268,013 4.500% |
-1,443,000 (-53.23%) |
Filing History |